✦ LIBER ✦

CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype

✍ Scribed by Helsby, N A; Lo, W-Y; Sharples, K; Riley, G; Murray, M; Spells, K; Dzhelai, M; Simpson, A; Findlay, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenetics of CYP2C19: functional

✍ Alain Li-Wan-Po; Thierry Girard; Peter Farndon; Candy Cooley; James Lithgow 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB

Novel drug metabolism indices for pharma

✍ Villagra, David; Goethe, John; Schwartz, Harold I; Szarek, Bonnie; Kocherla, Moh 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 957 KB

Clinical Pharmacogenetics Implementation

✍ Hicks, J K; Swen, J J; Thorn, C F; Sangkuhl, K; Kharasch, E D; Ellingrod, V L; S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 413 KB

Towards the implementation of CYP2D6 and

✍ Müller, Daniel J.; Kekin, Ivana; Kao, Amy C. C.; Brandl, Eva J. 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 153 KB

Effect of glycyrrhizin on CYP2C19 and CY

✍ Tu, J.-H.; Hu, D.-L.; Dai, L.-L.; Sun, Y.; Fan, L.; Zhang, M.; Tan, Z.-R.; Chen, 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 734 KB

Pharmacogenetics of cyclophosphamide and

✍ Pintip Ngamjanyaporn; Ammarin Thakkinstian; Oravan Verasertniyom; Porntip Chatch 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 149 KB